These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449 [TBL] [Abstract][Full Text] [Related]
4. Clinical inquiry: what medications are best for diabetic neuropathic pain? Page N; Deluca J; Crowell K J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101 [TBL] [Abstract][Full Text] [Related]
5. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy? Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228 [TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK. Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921 [TBL] [Abstract][Full Text] [Related]
7. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS]. Kiss G Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189 [TBL] [Abstract][Full Text] [Related]
9. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States. Yang M; Qian C; Liu Y Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study. Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268 [TBL] [Abstract][Full Text] [Related]
11. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis. Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185 [TBL] [Abstract][Full Text] [Related]
12. Pregabalin and duloxetine for the treatment of neuropathic pain disorders. Terneus W J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838 [TBL] [Abstract][Full Text] [Related]
13. Update on pharmacotherapy guidelines for treatment of neuropathic pain. Wallace JM Curr Pain Headache Rep; 2007 Jun; 11(3):208-14. PubMed ID: 17504648 [TBL] [Abstract][Full Text] [Related]
14. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies. Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557 [TBL] [Abstract][Full Text] [Related]
15. Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy. Wu JJ; Fleming KF Cutis; 2011 May; 87(5):249-50. PubMed ID: 21699129 [No Abstract] [Full Text] [Related]
16. A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin. Spiegel DR; Lappinen E; Gottlieb M Gen Hosp Psychiatry; 2010; 32(2):228.e5-7. PubMed ID: 20303003 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851 [TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care. Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096 [TBL] [Abstract][Full Text] [Related]
19. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin. Zhao Y; Sun P; Watson P Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196 [TBL] [Abstract][Full Text] [Related]
20. Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine. Scheinfeld N Dermatol Online J; 2013 Nov; 19(11):20616. PubMed ID: 24314785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]